The invention relates totricyclic compounds which are MKK4(mitogen-activated protein kinase kinase 4) inhibitors which selectively inhibit protein kinase kinase MKK4 over protein kinases JNK and MKK7. They are useful for promoting liver regeneration or reducing or preventing hepatocyte death.
这项发明涉及
三环化合物,它们是MKK4(丝裂原活化蛋白激酶激酶4)
抑制剂,可以选择性地抑制蛋白激酶激酶MKK4,而不影响蛋白激酶JNK和MKK7。它们可用于促进肝再生或减少或预防肝
细胞死亡。